检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《中国中西医结合杂志》2008年第8期735-738,共4页Chinese Journal of Integrated Traditional and Western Medicine
基 金:江西省卫生厅中医药基金项目(No.04A56)
摘 要:目的评估排毒保肾丸(即大黄虫丸加减)对延缓慢性肾功能衰竭(chronicrenalfailure,CRF)2、3期进程的影响。方法将283例慢性肾衰2、3期患者分为2组,治疗组151例(用排毒保肾丸3g,每天2次口服治疗);对照组132例(用包醛氧化淀粉酶胶囊每次5~10粒,每日3次餐后服);两组均2个月为1个疗程,治疗1、2个疗程后观察生活质量、临床症状评分及血清肌酐、尿素氮、内生肌酐清除率指标变化。结果两组临床症状积分、生活质量评分比较差异有统计学意义(t值分别为29.49、9.8,P<0.01)。治疗组总有效率70.86%(107/151例),对照组总有效率44.70%(59/132例),两组比较差异有统计学意义(χ2=18.69,P<0.01),治疗前两组血清肌酐、尿素氮、内生肌酐清除率比较,差异无统计学意义(P<0.05);治疗1、2个疗程后两组比较,差异有统计学意义(P<0.05,P<0.01)。结论排毒保肾丸对延缓慢性肾功能衰竭进程有效,能提高患者生活质量。Objective To assess the impact of Paidu Baoshen Pill ( PBP, modified Dahuang Zhechong Pill), in retarding the procession of chronic renal failure (CRF) of stage Ⅱ -Ⅲ. Methods The 283 patients of CRF stage Ⅱ -Ⅲ were randomly assigned to two groups, 151 patients in the treatment group treated with oral administra- tion of PBP 3 g twice a day, and 132 patients in the control group with oxidative amylase aldehyde enveloped capsule 5 -10 capsules thrice a day after meal. The course for both groups was 2 months, and the changes after 1 or 2 courses treatment in scoring of quality of life (QOL) and clinical symptoms, also in laboratory indexes including se- rum levels of creatinine (Cr), urea nitrogen (UN), and intrinsic creatinine clearance rate were observed. Results The total effective rate was 70. 86% ( 107/151 cases) in the treatment group and 44. 70% (59/132 cases) in the control group, showing significant difference between them (X2 = 18.69, P 〈 0. 01 ). Significant differences between groups were also shown in comparisons of scores of QOL and clinical symptoms after treatment. Inter-group comparison showed no difference in all the three indexes detected before treatment, but they did show statistical sig- nificance respectively after 1 and 2 courses of treatment ( P 〈 0. 05 and P 〈 0.01 ). Conclusion PBP could effec- tively retard the progression of chronic renal failure and significantly improve the QOL of patients.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229